The gene encoding SPBC1E8.02 is found within the genome of Schizosaccharomyces pombe . Genetic studies involving S. pombe strains have utilized SPBC1E8.02 in experiments such as genetic screens for extragenic suppressors and analyses of gene expression under different conditions, such as nitrogen starvation . SPBC1E8.02 has been identified as one of the genes induced in Δ tsc1 and Δ tsc2 strains, but not in the wild-type strain, after nitrogen starvation . This suggests a role in the cellular response to nutrient availability and stress .
SPBC1E8.02 is used in research for various purposes, including:
Antibody Production: Recombinant SPBC1E8.02 is utilized as an immunogen to generate antibodies for protein detection and localization studies .
Protein Interaction Studies: It is employed in assays to identify interacting partners and elucidate its role in cellular pathways .
Structural Biology: SPBC1E8.02 is used in crystallization studies to determine its three-dimensional structure and understand its mechanism of action .
| Property | Description |
|---|---|
| Product Code | CSB-PA524267XA01SXV |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Uniprot No. | O42967 |
| Immunogen | Recombinant Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) SPBC1E8.02 protein |
| Raised In | Rabbit |
| Species Reactivity | Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) |
| Tested Applications | ELISA, WB (ensure identification of antigen) |
| Form | Liquid |
| Conjugate | Non-conjugated |
| Storage Buffer | Preservative: 0.03% Proclin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
| Purification Method | Antigen Affinity Purified |
| Isotype | IgG |
| Clonality | Polyclonal |
| Product Type | Polyclonal Antibody |
| Immunogen Species | Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) |
| Lead Time | Made-to-order (14-16 weeks) |
| Target Names | SPBC1E8.02 |
| Usage | For Research Use Only. Not for use in diagnostic or therapeutic procedures. |
| ORF ID | Gene name | Possible function |
|---|---|---|
| SPCP31B10.09 | Unknown | |
| SPCC962.01 | ||
| SPAC1039.04 | Membrane transporter | |
| SPBC1773.17c | Glycerate and formate dehydrogenase | |
| SPBP26C9.01c | ||
| SPAC1039.01 | Amino acid permease | |
| SPBC887.17 | Uracil permease | |
| SPAC1399.02 | Membrane transporter | |
| SPBP35G2.11c | Zinc finger protein | |
| SPBC947.15c | Mitochondrial NADH dehydrogenase | |
| SPAP7G5.06 | Amino acid permease | |
| SPAC1039.03 | Esterase/lipase | |
| SPBC24C6.06 | gpa1 | Guanine nucleotide-binding protein |
| SPAC13G7.04c | mac1 | Membrane-anchored protein |
| SPAC27F1.05c | Aminotransferase | |
| SPBC1604.03c | Hypothetical protein | |
| SPCC1183.11 | MS ion channel | |
| SPCC31H12.01 | ||
| SPAC31G5.09c | spk1 | MAP kinase |
| SPAC11D3.03c | Conserved protein | |
| SPAC13F5.07c | Hypothetical protein | |
| SPAC27D7.03c | mei2 | RNA-binding protein |
| SPAC11H11.04 | mam2 | Pheromone P-factor receptor |
| SPAC186.04c | Pseudogene | |
| SPBC1683.02 | Adenosine deaminase | |
| SPBC660.07 | ntp1 | O-glycosyl hydrolase |
| SPBC1711.11 | Sorting nexin | |
| SPBC36B7.05c | Phosphatidylinositol(3)-phosphate-binding protein | |
| SPBC25B2.02c | mam1 | ABC transporter |
| SPBC2G5.09c | ||
| SPBPB2B2.01 | Amino acid permease | |
| SPCC1682.11c | Hypothetical protein | |
| SPCC550.07 | Acetamidase | |
| SPCC550.10 | meu8 | Betaine aldehyde dehydrogenase |
| SPCC622.11 | Hypothetical protein |
| ORF ID | Gene name | Possible function |
|---|---|---|
| SPAC21E11.04 | ppr1 | L-azetidine-2-carboxylic acid acetyltransferase |
| SPCC1020.14 | Tf2-12 tf2-5 | tf2-type transposon |
| SPCC794.05c | Pseudogene | |
| SPAC9.04 | Tf2-1 tf2-7 | tf2-type transposon |
| SPAC26A3.13c | Tf2-4 tf2-2 | tf2-type transposon |
| SPCC1494.11c | Tf2-13-pseudo | LTR retrotransposon tf2-type retrotransposon polyprotein with 1 frameshift |
| SPAC167.08 | Tf2-2 tf2-3 tf2-4 | tf2-type transposon |
| SPAC1F2.03 | ||
| SPAC2E1P3.03c | tf2-10 Tf2-3 | tf2-type transposon |
| SPAC2E1P3.03 | ||
| SPBC9B6.02c | tf2-8 Tf2-9 | Retrotransposable element |
| SPAPB18E9.03c | Hypothetical protein | |
| SPBC1E8.04c | Tf2-10-pseudo | Frameshifted LTR retrotransposon polyprotein |
| SPBC660.09 | Hypothetical protein | |
| SPAC3F10.16c | GTPase | |
| SPBC1271.08c | Hypothetical protein | |
| SPBC1271.07c | Acetyltransferase | |
| SPAC57A10.01 | pas1 | Pcl-like cyclin |
| SPAC19E9.03 | ||
| SPBC2G2.04c | mmf1 pmf1 | Conserved protein |
| SPBP4H10.12 | Conserved protein | |
| SPAC821.10c | sod1 | Cu,Zn-superoxide dismutase |
| SPBC211.07c | ubc8 | Ubiquitin-conjugating enzyme |
| SPAC29B12.13 | Hypothetical protein | |
| SPAC2F3.08 | sut1 | α-Glucoside transporter |
| SPCC1450.13c | Riboflavin synthase | |
| SPAC3C7.02c | Hypothetical protein | |
| SPCC704.04c | Hypothetical protein | |
| SPAC17H9.03 | inv1 | Beta-fructofuranosidase |
| SPAC19G1.09 | Hypothetical protein | |
| SPCC1281.04c | hrr1 | Putative transcription factor |
| SPBC30D10.07 | Hypothetical protein | |
| SPAC1834.11c | fbp1 | Fructose-1,6-bisphosphatase |
KEGG: spo:SPBC1E8.02
STRING: 4896.SPBC1E8.02.1
SPBC1E8.02 is an uncharacterized ubiquitin-like protein in the fission yeast Schizosaccharomyces pombe. It belongs to the ubiquitin protein family, which plays crucial roles in protein regulation, degradation pathways, and cellular signaling . Its significance lies in understanding the evolution and function of ubiquitin-like modifier systems across eukaryotes. S. pombe is an excellent model organism that shares more features with metazoan cells than S. cerevisiae does, making findings potentially more translatable to higher eukaryotes including humans .
SPBC1E8.02 is classified as a predicted ubiquitin family protein based on sequence homology and structural predictions . Unlike well-characterized ubiquitin-like modifiers such as SUMO or FAT10, SPBC1E8.02 remains largely uncharacterized. To properly classify it, researchers should perform detailed sequence analysis using multiple sequence alignment tools to compare it with known ubiquitin-like modifiers, followed by phylogenetic analysis to determine its evolutionary relationship to other members of the family. Domain structure analysis using tools like InterPro, Pfam, or SMART can identify conserved ubiquitin domains and any unique structural features .
For initial characterization of SPBC1E8.02, a multi-faceted approach is recommended:
Expression profiling: Determine when and where the protein is expressed using RNA-seq and quantitative proteomics
Subcellular localization: Generate fluorescently tagged versions (e.g., GFP-SPBC1E8.02) to track localization, similar to the approaches used for Dis2.NEGFP and Sds21.NEGFP characterization
Genetic analysis: Create knockout strains (Δspbc1e8.02) to observe phenotypic effects, followed by complementation studies
Initial interaction studies: Perform immunoprecipitation followed by mass spectrometry to identify binding partners
Basic structural analysis: Express and purify the recombinant protein for circular dichroism spectroscopy to determine secondary structure elements
These methods establish a foundation for further functional studies by providing insights into expression patterns, cellular localization, and potential interaction networks.
To determine if SPBC1E8.02 functions as a true ubiquitin-like modifier, design experiments that test for the hallmark characteristics of these proteins:
E1-E2-E3 enzyme cascade analysis:
Test for activation by known E1 enzymes (UBA1, UBA6) using in vitro thioester formation assays
Identify potential E2 enzymes through yeast two-hybrid screens or in vitro conjugation assays
Look for E3 ligase interactions using protein interaction studies
Conjugation assays:
Develop antibodies specific to SPBC1E8.02 to detect endogenous conjugates
Express tagged versions (His6-SPBC1E8.02) to purify conjugates under denaturing conditions
Use mass spectrometry to identify substrate proteins
Functional testing:
These approaches will provide evidence for or against SPBC1E8.02 functioning as a canonical ubiquitin-like modifier versus having other roles.
For chromatin immunoprecipitation (ChIP) experiments involving SPBC1E8.02, implement these methodological strategies:
Crosslinking optimization:
Test different formaldehyde concentrations (0.5-3%) and crosslinking times (5-30 minutes)
Consider dual crosslinking with disuccinimidyl glutarate followed by formaldehyde for protein-protein interactions
Antibody selection/validation:
Generate specific antibodies against SPBC1E8.02 or use epitope tags (FLAG, HA, or TAP)
Validate antibody specificity using knockout strains as negative controls
ChIP-seq implementation:
Data analysis pipeline:
Use specialized peak calling algorithms suitable for histone modifications or transcription factors
Correlate SPBC1E8.02 binding sites with RNA Pol II occupancy patterns to determine potential regulatory roles
Compare binding profiles with known chromatin marks and transcription factors
This approach will enable the identification of genomic regions associated with SPBC1E8.02 and provide insights into its potential role in chromatin biology.
For effective quantitative proteomic analysis of SPBC1E8.02 interactions:
Sample preparation:
Analytical approach:
Implement SILAC (Stable Isotope Labeling with Amino acids in Cell culture) for quantitative comparison
Consider proximity-dependent biotin identification (BioID) for detecting transient interactions
Use Multiple Reaction Monitoring (MRM) for targeted quantification of specific interactions
Comparative analysis:
Compare SPBC1E8.02 interactome under different conditions (normal growth, stress, cell cycle stages)
Create interaction networks using statistical thresholds to distinguish true interactions
Validate key interactions through reciprocal IP, yeast two-hybrid, or FRET analysis
Data interpretation:
Categorize interacting proteins by cellular function and localization
Determine enrichment of interaction partners during specific physiological conditions
Identify potential substrates if SPBC1E8.02 functions as a modifier
This comprehensive approach will build a quantitative and condition-specific interaction map for SPBC1E8.02.
To determine if SPBC1E8.02 is involved in cell cycle regulation in S. pombe, implement these methodological approaches:
Cell cycle synchronization and expression analysis:
Synchronize cells using centrifugal elutriation or chemical blocks
Monitor SPBC1E8.02 expression, protein levels, and post-translational modifications throughout the cell cycle
Construct a strain with regulatable promoter to modulate SPBC1E8.02 levels
Cell cycle phenotype characterization:
Analyze Δspbc1e8.02 mutants for cell cycle defects (elongated cells, aberrant nuclei)
Perform FACS analysis to identify potential cell cycle stage accumulation
Use live-cell imaging with GFP-tagged SPBC1E8.02 to track localization changes through the cell cycle
Genetic interaction analysis:
Molecular mechanism investigation:
Identify substrates modified during specific cell cycle phases using synchronized cells
Test if SPBC1E8.02 affects the stability of key cell cycle regulators
Examine effects on centromere structure or function using ChIP assays
These approaches systematically evaluate SPBC1E8.02's role in cell cycle regulation from multiple perspectives.
To investigate SPBC1E8.02's potential interaction with or modification of the SUMO pathway:
In vitro competition assays:
SUMO conjugation analysis:
Examine global SUMO conjugation patterns in Δspbc1e8.02 strains versus wild-type
Use quantitative proteomics to compare the SUMOylome in the presence/absence of SPBC1E8.02
Test if SPBC1E8.02 overexpression affects SUMO-dependent processes like PML body formation
Pathway component interactions:
Investigate direct interactions with SUMO pathway components (E1, E2, E3, SUMO proteases)
Test genetic interactions between SPBC1E8.02 and SUMO pathway genes
Examine co-localization patterns using fluorescently tagged proteins
Functional assessment:
Create a table comparing SUMO-dependent phenotypes in wild-type and SPBC1E8.02 mutant cells:
| Phenotype | Wild-type | Δspbc1e8.02 | SPBC1E8.02 overexpression |
|---|---|---|---|
| Global SUMOylation | Baseline | ? | ? |
| DNA damage response | Normal | ? | ? |
| Chromosome segregation | Normal | ? | ? |
| Heat shock response | Normal | ? | ? |
| Cell cycle progression | Normal | ? | ? |
These approaches will determine whether SPBC1E8.02 functions as a regulator of the SUMO pathway, similar to FAT10.
To study how environmental stress affects SPBC1E8.02 expression and function:
Stress induction and expression analysis:
Expose S. pombe cultures to various stressors (oxidative, heat, osmotic, DNA damage)
Measure changes in SPBC1E8.02 mRNA levels using RT-qPCR
Monitor protein levels and post-translational modifications using western blotting
Implement time-course experiments to track expression dynamics during stress and recovery
Stress phenotype characterization:
Compare survival rates of wild-type and Δspbc1e8.02 strains under different stress conditions
Examine cellular morphology and localization changes of GFP-tagged SPBC1E8.02 during stress
Monitor global changes in the SPBC1E8.02 interactome and "modificome" during stress response
Transcriptomic analysis:
Perform RNA-seq comparing wild-type and Δspbc1e8.02 strains under normal and stress conditions
Create a stress-response gene expression signature for SPBC1E8.02 deletion
Identify transcription factors potentially regulated by SPBC1E8.02
Stress signaling pathway analysis:
Test if SPBC1E8.02 interacts with stress-activated protein kinases or transcription factors
Investigate if SPBC1E8.02 influences the activation of stress response pathways
Examine potential interactions with the Wsh3/Tea4 stress pathway scaffold that modulates polarized growth following osmotic stress
These methods will provide a comprehensive understanding of SPBC1E8.02's role in stress responses.
To optimize genome-wide genetic interaction screening for SPBC1E8.02 function:
Screen design optimization:
Implement a synthetic genetic array (SGA) approach similar to that used for ell1, eaf1, and SPAC6G9.15c
Consider using quantitative fitness analysis rather than binary growth/no-growth scoring
Include conditional alleles of essential genes to expand the screen's coverage
Design the screen to detect both negative (synthetic sick/lethal) and positive (suppressor) interactions
Technical considerations:
Use robotics for high-throughput crosses and selection steps to minimize variability
Implement barcode-based parallel analysis for higher throughput and quantitative fitness measurements
Include multiple replicates and appropriate controls to establish statistical significance thresholds
Data analysis framework:
Generate genetic interaction profiles correlating SPBC1E8.02 with known biological processes
Cluster genetic interactions to identify functional groups
Create a hierarchical model of genetic interactions similar to:
| Interaction strength | Number of genes | Enriched biological processes | Key interactors |
|---|---|---|---|
| Strong negative | ? | ? | ? |
| Moderate negative | ? | ? | ? |
| No interaction | ? | ? | ? |
| Moderate positive | ? | ? | ? |
| Strong positive | ? | ? | ? |
Validation strategy:
Confirm key interactions through manual tetrad dissection
Perform in-depth phenotypic analysis of double mutants showing strong interactions
Validate molecular mechanisms through biochemical approaches
This optimized approach will provide a comprehensive functional map of SPBC1E8.02 within the S. pombe genetic landscape.
To investigate SPBC1E8.02's potential roles in chromatin regulation:
Chromatin association mapping:
Perform ChIP-seq to map genome-wide binding sites of SPBC1E8.02
Compare binding profiles with histone modifications, transcription factors, and chromatin remodelers
Use DamID as an alternative approach to validate ChIP-seq findings
Implement the quantitative proteomic approach described by Wang for analyzing chromatin-bound proteins
Chromatin state analysis:
Transcriptional impact assessment:
Perform RNA-seq to identify genes differentially expressed in Δspbc1e8.02 strains
Use PRO-seq to measure nascent transcription and identify direct effects
Implement ChIP-seq for RNA Polymerase II to detect changes in transcriptional dynamics
Mechanistic investigation:
Test interactions with chromatin modifying enzymes and remodeling complexes
Investigate if SPBC1E8.02 directly modifies histones or chromatin factors
Examine potential roles in processes like transcription, DNA replication, or DNA repair
These approaches will provide comprehensive insights into SPBC1E8.02's potential functions in chromatin biology.
To identify the enzymatic machinery associated with SPBC1E8.02 conjugation:
E1 activating enzyme identification:
Test in vitro activation by known E1s (UBA1, UBA6) through ATP-PPi exchange assays
Perform thioester formation assays with recombinant SPBC1E8.02 and potential E1s
Investigate if SPBC1E8.02 competes with other ubiquitin-like modifiers for activation, similar to FAT10's interference with SUMO activation
E2 conjugating enzyme screening:
Conduct yeast two-hybrid screens using SPBC1E8.02 as bait against E2 libraries
Test thioester formation with potential E2s in vitro
Perform pulldown assays with tagged SPBC1E8.02 followed by western blotting for E2s
Create an E2 conjugating enzyme activity profile comparing SPBC1E8.02 with other ubiquitin-like proteins:
| E2 enzyme | Ubiquitin | SUMO | SPBC1E8.02 |
|---|---|---|---|
| UBC1 | + | - | ? |
| UBC2 | + | - | ? |
| UBC3 | + | - | ? |
| UBC4 | + | - | ? |
| UBC9 | - | + | ? |
E3 ligase identification:
Screen for interactions between SPBC1E8.02 and known E3 ligases
Perform in vitro conjugation assays with candidate E3s
Use proteomics to identify proteins that co-purify with tagged SPBC1E8.02
Deconjugating enzyme identification:
Test known deubiquitinating enzymes (DUBs) for activity against SPBC1E8.02 conjugates
Screen for genetic interactions between SPBC1E8.02 and DUB mutants
Identify proteases specific for SPBC1E8.02 using activity-based probes
This systematic approach will define the full enzymatic cascade required for SPBC1E8.02 function as a protein modifier.
To effectively compare SPBC1E8.02 function across species:
Sequence and structural comparison:
Perform phylogenetic analysis to identify orthologs in S. cerevisiae and other organisms
Compare protein domain architectures to identify conserved and divergent features
Use structural prediction tools to model and compare three-dimensional structures
Complementation studies:
Express SPBC1E8.02 in S. cerevisiae orthologs' deletion strains to test functional conservation
Introduce orthologs from other species into Δspbc1e8.02 S. pombe to assess rescue capacity
Analyze domain-swapping chimeras to identify functionally crucial regions
Comparative phenotypic analysis:
Create a table comparing phenotypes of ortholog deletions across species:
| Phenotype | S. pombe Δspbc1e8.02 | S. cerevisiae Δortholog | Human cells (siRNA knockdown) |
|---|---|---|---|
| Growth rate | ? | ? | ? |
| Cell cycle effects | ? | ? | ? |
| Stress response | ? | ? | ? |
| Protein homeostasis | ? | ? | ? |
Molecular function comparison:
Compare interaction networks across species using orthologous proteins
Examine conservation of substrate specificity if SPBC1E8.02 functions as a modifier
Investigate if regulatory mechanisms are conserved across species
This comparative approach leverages evolutionary relationships to gain insight into conserved functions and species-specific adaptations of SPBC1E8.02.
When designing diversity and inclusion practices for collaborative research on SPBC1E8.02:
Team composition and dynamics:
Assemble diverse research teams considering gender, ethnicity, career stage, and disciplinary backgrounds
Implement practices that ensure equitable contribution and acknowledgment from all team members
Create an inclusive environment that values different perspectives and approaches to scientific problems
Consider research showing that diverse teams report better communication and greater satisfaction with research processes
Methodological considerations:
Design experiments that acknowledge potential biases in traditional research approaches
Ensure protocols are accessible and implementable across different resource settings
Consider multiple theoretical frameworks for interpreting results
Include team members with complementary expertise in protein biochemistry, genetics, and computational biology
Knowledge sharing and access:
Develop accessible documentation and protocols to facilitate broader participation
Share reagents, strains, and tools with researchers from institutions with fewer resources
Consider open science practices including pre-registration of studies and data sharing
Publish in both open access and traditional journals to maximize accessibility
Community engagement:
Engage with the broader S. pombe research community to share resources and knowledge
Develop training opportunities for researchers from underrepresented groups
Consider the power dynamics between researchers and research communities
Acknowledge all contributions to the research, including technical support staff
For integrating computational and experimental approaches to characterize SPBC1E8.02:
Iterative analysis workflow:
Begin with computational predictions (structure, function, interactions) to guide initial experiments
Use experimental results to refine computational models in an iterative cycle
Implement a data integration platform that combines results from multiple approaches
Develop a structured workflow similar to:
| Stage | Computational approach | Experimental validation | Integration method |
|---|---|---|---|
| Initial characterization | Homology modeling, sequence analysis | Expression verification, localization | Feature confirmation |
| Functional prediction | Interaction network prediction, domain analysis | Y2H screens, co-IP | Network enrichment |
| Mechanism elucidation | Molecular dynamics simulations | Mutational analysis, in vitro assays | Structural validation |
| Systems-level understanding | Pathway modeling, genetic interaction prediction | Genetic screens, global -omics | Pathway mapping |
Machine learning implementation:
Train prediction models using known ubiquitin-like modifiers to identify potential substrates
Validate predictions experimentally to improve model accuracy
Use active learning approaches to prioritize experiments with highest information content
Data management considerations:
Implement FAIR (Findable, Accessible, Interoperable, Reusable) data principles
Develop standardized data formats that capture both computational and experimental results
Create visualization tools that integrate multiple data types
Interdisciplinary collaboration structure:
Form teams with both wet-lab and computational expertise
Establish common language and regular communication channels
Develop shared project milestones that require input from both approaches
Include researchers with diverse disciplinary backgrounds to maximize the "edge effect" where different knowledge bases interact
This integrated approach leverages the strengths of both computational and experimental methods while minimizing their individual limitations.
The most promising future research directions for understanding SPBC1E8.02 function include:
Systems biology approach:
Create a comprehensive genetic and protein interaction map for SPBC1E8.02
Develop mathematical models of SPBC1E8.02 function within cellular networks
Integrate multiple -omics datasets to understand its role at the systems level
Evolutionary functional analysis:
Conduct comparative studies across diverse fungal species to trace functional evolution
Identify conserved interaction partners across evolutionary distance
Investigate how SPBC1E8.02 function may have diverged from other ubiquitin-like proteins
Structure-function relationships:
Determine the three-dimensional structure of SPBC1E8.02 using X-ray crystallography or cryo-EM
Map functional domains through mutational analysis
Design structure-based experiments to understand substrate recognition
Physiological role clarification:
Investigate SPBC1E8.02 function under different growth conditions and stresses
Examine its role in specialized cellular processes like meiosis or quiescence
Study potential roles in protein quality control and homeostasis
These directions will contribute to understanding not only SPBC1E8.02 specifically but also broaden our knowledge of ubiquitin-like proteins and their diverse functions in eukaryotic cells.
To contribute SPBC1E8.02 data to community resources and standardize nomenclature:
Data submission guidelines:
Submit sequence data to GenBank/ENA/DDBJ with complete annotation
Deposit structural data in the Protein Data Bank with detailed metadata
Share proteomic datasets via ProteomeXchange repositories
Contribute genetic interaction data to BioGRID or similar databases
Nomenclature standardization:
Follow the International Protein Nomenclature Guidelines when naming protein isoforms or domains
Use American spelling consistently in publications and database submissions
If a specific function is discovered, propose a systematic name to the S. pombe research community
Avoid creating new abbreviations; instead, use established nomenclature for post-translational modifications
Resource development:
Collaborative framework:
Participate in community-wide efforts to standardize experimental approaches
Engage with nomenclature committees to propose function-based naming if appropriate
Share reagents through repositories like Addgene or directly with other researchers
Participate in collaborative research networks focused on ubiquitin-like proteins
These contributions will enhance the accessibility and utility of SPBC1E8.02 research for the broader scientific community.
To ensure reproducibility in SPBC1E8.02 research:
Strain and reagent standardization:
Deposit strains in community repositories with complete genotype information
Verify strain identities through genotyping before key experiments
Use consistent growth conditions and media formulations across experiments
Include detailed methodology for recombinant protein production including expression systems, tags, and purification protocols
Experimental design principles:
Follow the five key steps of experimental design outlined in search result :
Define variables and how they are related
Write specific, testable hypotheses
Design experimental treatments to manipulate independent variables
Assign subjects to groups appropriately
Plan precise measurements of dependent variables
Include positive and negative controls in all experiments
Determine appropriate sample sizes through power analysis
Implement randomization and blinding where appropriate
Data collection and analysis transparency:
Pre-register experimental designs and analysis plans when possible
Report all exclusion criteria and outliers
Share raw data alongside publications
Document complete computational workflows and code
Provide detailed statistical analysis methods including specific tests and corrections
Validation requirements:
Confirm key findings using multiple independent methods
Validate antibody specificity using appropriate controls (e.g., knockout strains)
Replicate critical experiments in independent laboratories when possible
Test reproducibility across different S. pombe strain backgrounds